choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Liraglutide

Liraglutide Newsletter
  • Nearly 17 Million Young Americans Could Benefit From Ozempic-like Drugs 04 Aug 2025 16:00 GMT

    … were appropriate candidates for these medications could receive them after shared … semaglutide (Ozempic, Rybelsus and Wegovy), liraglutide (Saxenda and Victoza), Bydureon BCise … .S. Food and Drug Administration criteria for GLP-1RA treatment. Over-the …

  • Noom launches low dose of compounded weight-loss drug for $119 04 Aug 2025 11:28 GMT

    … gastrointestinal side effects. In clinical trials, they have resulted in … from Lilly Direct and generic liraglutide, an older GLP-1 … U.S. Food and Drug Administration to allow compounding pharmacies … Egler, Noom’s chief medical officer, said patients who want …

  • Diabetic patient can return to normal blood sugar levels without medication: PGI Chandigarh 02 Aug 2025 17:10 GMT

    … it for life, with pills and blood sugar logs … in the normal range -- drug-free. What happened? … , both treatment groups -- one using newer medications like liraglutide and dapagliflozin … resistance and worsening diabetes. Doctors now understand that two major …

  • Semaglutide and Liraglutide linked to Elevated Risk of Optic Nerve Damage in Seniors With Type 2 Diabetes: JAMA 01 Aug 2025 22:27 GMT

    … second-line antidiabetic drugs. Semaglutide (HR 1.39) and liraglutide (HR 1 … sex, White race, and dual Medicare-Medicaid eligibility were associated with increased …

  • Lupin obtains FDA nod for liraglutide, glucagon injectable products 01 Aug 2025 16:49 GMT

    … the Food and Drug Administration for liraglutide injection single-patient- … Nordisk’s Victoza.  The medicaition is indicated as an adjunct … data. [Read more: FDA gives Lupin tentative nod for … is indicated for the treatment of severe hypoglycemia in pediatric …

  • Targeting energy expenditure: the next wave for obesity drugs 31 Jul 2025 18:08 GMT

    … next generation of obesity treatments must include agents that … -based Rivus Pharmaceuticals. In a Phase IIa trial (NCT05284617) of … body mass over liraglutide alone. Liraglutide is sold by … its US Food and Drug Administration (FDA) approval withdrawn over …

  • Weight loss drug demand continues to grow in the UK – here’s what’s being done to keep supplies readily available 31 Jul 2025 14:50 GMT

    … providers for access to these medicines – despite the potential risks … Several new weight loss drugs are undergoing trials in the UK. … and 2031. Once a pharmaceutical product is outside of its … NHS for the treatment of diabetes. The liraglutide brand Saxenda is …

  • Tirzepatide Shows Noninferiority to Dulaglutide for Rate of MACE 04 Aug 2025 21:02 GMT

    … and more.2 Treatment included either once weekly … popular antiobesity medications, including semaglutide (Ozempic, Wegovy), liraglutide (Victoza, … head-to-head trial, reinforcing its benefit … , strongest antihypertensive effects. Drug Topics. February 13, …

  • Can I use Ozempic after gastric bypass? 31 Jul 2025 17:35 GMT

    … loss drugs Several GLP-1 drugs are … FDA-approved specifically for weight loss. In Wegovy clinical trialsliraglutide medications, but liraglutide can still help with weight loss. A randomized clinical trial … weeks of treatment, the liraglutide group lost an …

  • Can Ozempic cause muscle loss? 04 Aug 2025 18:58 GMT

    … rest being fat. Clinical trials show semaglutide (the active … Loss A 2021 clinical trial found that participants taking … GLP-1 drugs, such as exenatide (Byetta) and liraglutide (Victoza), … Medications That Can Help Prevent Ozempic Muscle Loss? New treatments

Satisfied with the content?

Continue to create your account.